Skip to product information
WELLlife™ COVID-19/Influenza A&B Test-25/Box
$249.99
The WELLlife™ COVID-19/Influenza A&B Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens.
Key Benefits
- Cost-Effective: Differentiate between SARS-COV-2, influenza A, and influenza B antigens with a single test using an anterior nasal swab specimen.
- Rapid Results: available in 10 minutes allows for testing and treatment decision-making during the same office visit.
- Quality Assurance: The outstanding clinical performance with external controls available, enables physicians to make quicker and more confident decisions.
- Extended Detection Window: Offers a broader detection window for differentiation of SARS-COV-2, influenza A, and influenza B antigens within five days of symptom onset.
- Wide Storage Temperature: 36°F-86°F (2°C-30°C) allows for easier product storage.
| Tests/Box | 25 |
| Type | Immunochromatographic assay |
| Time to results | 10 minutes |
| Sensitivity | Flu A: 85.9% Flu B: 86.8% COVID: 87.5% |
| Specificity | Flu A: 99.7% Flu B: 99.7% COVID: 99.7% |
| Detectable analytes | Influenza A/B and SARS-CoV-2 antigens |
| Format | Cassette read procedure |
| Sample type |
Anterior nasal swab |
| External controls | Not included |
| CLIA complexity | Waived |
| CPT code | 87812-QW |
| FDA clearance | 510(k) |
Product Ships with minimum 60 days dating; Please reach out to your account executive for exact expiration date.